information concerning the Respondent and to ensure that MPRP is authorized to
receive the health care records of the Respondent, including, but not limited to,
mental health and drug or alcohol evaluation and treatment records. The
Respondent shall not withdraw his release/consent;

(e) If, upon the authorization of MPRP, the Respondent transfers to a rehabilitation
program in another state, the Respondent’s failure to comply with any term or
condition of that state’s [the out-of-state’s] rehabilitation program constitutes a
violation of this Order. The Respondent shall also sign any out-of-state written
release/consent forms to authorize the Board to exchange with (i.e., disclose to
and receive from the out-of-state program verbal and written information
concerning the Respondent and to ensure that the Board is authorized to receive
the medical records of the Respondent, including, but not limited to, mental
health and drug or alcohol evaluation and treatment records. The Respondent
shall not withdraw the release/consent;

(f) The Respondent's failure to comply with any of the above terms or conditions,
including terms and conditions of the Participant Rehabilitation Agreement(s)
or Participant Rehabilitation Plan(s), constitutes a violation of this Order
Terminating Suspension and Imposing Probation;

(2) The Respondent is prohibited from prescribing and dispensing controlled dangerous
substance medications until after he has successfully completed the courses
described in probation condition (3). The prohibition on prescribing and dispensing

may be administratively terminated through an order of the Panel upon the
Respondent’s proof of successful completion of the courses. The following conditions
also apply:

(a) the Respondent shall not delegate any physician assistant the prescribing of
controlled dangerous substances;

(b) the Respondent is prohibited from certifying patients for the medical use of
cannabis;

(c) the Panel may issue administrative subpoenas to the Maryland Prescription
Drug Monitoring Program on a quarterly basis for the Respondent’s Controlled
Dangerous Substances (“CDS”) prescriptions. The administrative subpoenas
will request the Respondent’s prescriptions from the beginning of each quarter;

(d) the Respondent agrees that the CDS Registration issued by the Office of
Controlled Substances Administration will be restricted to the same categories
of CDS medications as limited by this Order Terminating Suspension and
Imposing Probation; and

(3) Within SIX (6) MONTHS, the Respondent is required to take and successfully
complete two courses, (1) a course in prescribing of controlled dangerous substances

 

es cupansegenceeunqayeceeigenugeess eae
